CareTechnology ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/2
2020
2021/2
2021
2022/2
2022
2023/2
2023
2024/2
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  15.7% 21.0% 8.7% 6.3% 7.7%  
Credit score (0-100)  13 5 27 37 30  
Credit rating  BB B BB BBB BB  
Credit limit (kDKK)  0.0 -0.0 -0.0 0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/2
2020
2021/2
2021
2022/2
2022
2023/2
2023
2024/2

Net sales  0 0 0 0 0  
Gross profit  -37.2 -35.5 -15.6 -4.6 -3.9  
EBITDA  -37.2 -35.5 -15.6 -4.6 -3.9  
EBIT  -37.2 -35.5 -15.6 -4.6 -3.9  
Pre-tax profit (PTP)  -37.5 -35.6 -17.0 53.7 -78.4  
Net earnings  -37.5 -35.6 -13.4 55.1 -78.4  
Pre-tax profit without non-rec. items  -37.5 -35.6 -17.0 53.7 -78.4  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/2
2020
2021/2
2021
2022/2
2022
2023/2
2023
2024/2

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  32.1 -3.2 -16.6 38.5 -39.9  
Interest-bearing liabilities  8.1 10.7 66.3 71.1 79.8  
Balance sheet total (assets)  44.6 11.1 55.0 115 45.6  

Net Debt  -32.6 7.3 66.3 70.9 49.9  
 
See the entire balance sheet

Volume 
2019
2020/2
2020
2021/2
2021
2022/2
2022
2023/2
2023
2024/2

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -37.2 -35.5 -15.6 -4.6 -3.9  
Gross profit growth  0.0% 4.5% 56.2% 70.3% 15.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  45 11 55 115 46  
Balance sheet change%  -41.3% -75.2% 397.7% 109.2% -60.4%  
Added value  -37.2 -35.5 -15.6 -4.6 -3.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 -3.0 -4.0 -5.0  

Profitability 
2019
2020/2
2020
2021/2
2021
2022/2
2022
2023/2
2023
2024/2
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -61.7% -120.6% -36.4% 60.8% -72.9%  
ROI %  -67.4% -139.5% -40.6% 64.6% -77.2%  
ROE %  -73.7% -164.9% -40.6% 117.9% -186.5%  

Solidity 
2019
2020/2
2020
2021/2
2021
2022/2
2022
2023/2
2023
2024/2
Equity ratio %  71.9% -22.6% -23.2% 33.4% -46.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  87.6% -20.4% -426.3% -1,536.7% -1,272.8%  
Gearing %  25.2% -333.3% -398.7% 184.8% -200.0%  
Net interest  0 0 0 0 0  
Financing costs %  6.5% 0.6% 3.5% 4.6% 7.0%  

Liquidity 
2019
2020/2
2020
2021/2
2021
2022/2
2022
2023/2
2023
2024/2
Quick Ratio  3.6 0.8 0.4 0.4 0.3  
Current Ratio  3.6 0.8 0.4 0.4 0.3  
Cash and cash equivalent  40.7 3.5 0.0 0.2 29.9  

Capital use efficiency 
2019
2020/2
2020
2021/2
2021
2022/2
2022
2023/2
2023
2024/2
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  32.1 -3.2 -42.7 -47.8 -55.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/2
2020
2021/2
2021
2022/2
2022
2023/2
2023
2024/2
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0